IHC staining results also revealed that PD-L1 expression and tumor-infiltrating macrophage marker CD68 appeared in the tumor (Fig. 3A–B) before BRAF and MEK inhibitors treatment in December 2013. This evidence concerns the gene MAP2K7 and neoplasm.